Constitutive activation of PI3K/mTOR signaling occurs in the majority of human acute myeloid leukemia (AML) and likely results from a variety of mechanisms, including alterations in cellular growth factors and mutations in FLT3, c-kit, and Ras pathway proteins (32–34). The gene discussed is KIT; the disease is acute myeloid leukemia.